Skip to main content
Clinical Trials/NCT06295874
NCT06295874
Recruiting
Not Applicable

Effect of Aromatherapy Massage Applıed to Intensıve Care Patıents on Physıologıcal Parameters, Paın, Anxıety and Intensıve Care Comfort

Nilgün Erdoğan1 site in 1 country61 target enrollmentJanuary 5, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Respiratory Insufficiency
Sponsor
Nilgün Erdoğan
Enrollment
61
Locations
1
Primary Endpoint
Patient Introduction Form
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Patients in the intensive care unit (ICU) experience physical and psychological discomfort, including pain. Anxiety is a condition frequently encountered in the ICU. The hospital environment, especially the ICU, is reported as a significant cause of anxiety for patients. Comfort is a holistic, subjective and multidimensional concept that is affected by physical, environmental, social and psycho-spiritual contexts and changes over time and space. Comfort in intensive care is often associated with pain relief and end-of-life care. Assessment tools have been developed to measure patient comfort in the ICU, including levels of pain, delirium, and sedation. This work; Patients who are monitored in intensive care under high-flow and oxygen are treated with a mixture of lavender, thyme and eucalyptus oil (20 ml; lavender oil 5 drops, thyme oil 4 drops, eucalyptus oil 3 drops and 20 ml almond oil) twice a day for three days. This study was conducted to determine the effect of aromatherapy massage applied for a total of 30 minutes on some physiological parameters, pain, anxiety and intensive care comfort of the patients.

Registry
clinicaltrials.gov
Start Date
January 5, 2023
End Date
August 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Nilgün Erdoğan
Responsible Party
Sponsor Investigator
Principal Investigator

Nilgün Erdoğan

Principal Investigator

Nigde Omer Halisdemir University

Eligibility Criteria

Inclusion Criteria

  • 18 years of age and over,
  • Conscious patients,
  • Staying in intensive care for 24 hours or more,
  • Those with stable hemodynamic status,
  • Receiving O2 therapy,
  • Intubated patients, patients who have passed 24 hours after being extubated,
  • Those whose saturation level is 85 and above

Exclusion Criteria

  • Patients with peripheral neuropathy or quadriplegia,
  • Patients with open wounds on their body,
  • Patients receiving analgesia and sedation infusion,
  • Patients who are sedated,
  • Patients in delirium,
  • Patients with an allergy detected before starting the application,
  • Patients with a GKS (Glasgow Coma Scale) score of 3 and below

Outcomes

Primary Outcomes

Patient Introduction Form

Time Frame: 2 years

The "Patient Introduction Form" prepared by the researcher based on the literature in order to obtain information about the characteristics of the patients who will form the sample includes questions such as the medical diagnosis of the patients, age, gender, chronic diseases, length of stay in intensive care, use of analgesics and sedative drugs.

Secondary Outcomes

  • Patient Follow-up Form(2 years)

Study Sites (1)

Loading locations...

Similar Trials